1.
Morrell DS, Rubenstein DS, Briggaman RA, Fine JD, Pulkkinen L, Uitto J. Congenital pyloric atresia in a newborn with extensive aplasia cutis congenita and epidermolysis bullosa simplex.
Br J Dermatol. 2000 Dec;143(6):1342-3.
2.
Wheeler CE Jr, Carroll MA, Groben PA, Briggaman RA, Prose NS, Davis DA.
Autosomal dominantly inherited generalized basaloid follicular hamartoma syndrome: report of a new disease in a North Carolina family.
J Am Acad Dermatol. 2000 Aug;43(2
Pt 1):189-206.
3.
Fine JD, Eady RA, Bauer EA, Briggaman RA, Bruckner-Tuderman L, Christiano A,
Heagerty A, Hintner H, Jonkman MF, McGrath J, McGuire J, Moshell A, Shimizu H,
Tadini G, Uitto J. Revised classification system for inherited epidermolysis bullosa:
Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa.
J Am Acad Dermatol. 2000 Jun;42(6):1051-66.
4.
Cooley JE, Briggaman RA, Cronce DJ, Banes AJ, O'Keefe EJ. Hailey-Hailey disease keratinocytes: normal assembly of cell-cell junctions in vitro.
J Invest Dermatol. 1996
Dec;107(6):877-81.
5.
Skidmore RA, Woosley JT, Briggaman RA. Leukokeratoderma estrovale digitorum inversa.
J Am Acad Dermatol. 1996 Jun;34(6):1074-6.
6.
Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB. Passive transfer of antilaminin 5 antibodies induces subepidermal blisters in neonatal mice. J clin Invest.
1996;98:1509-1518.
7.
Borradori L, Caldwell JB, Briggaman RA, Burr CE, Gammon WR, James WD, Yancey
KB. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Arch Dermatol.
1995 May;131(5):590-5.
8.
Jones DA, Hunt SW 3rd, Prisayanh PS, Briggaman RA, Gammon WR. Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain.
J Invest
Dermatol. 1995 Feb;104(2):231-5.
9.
Ivker RA, Woosley J, Briggaman RA. Calciphylaxis in three patients with end-stage renal disease.
Arch Dermatol. 1995 Jan;131(1):63-8.
10.
Cairns BA, Herbst CA, Sartor BR, Briggaman RA, Koruda MJ. Peristomal pyoderma gangrenosum and inflammatory bowel disease.
Arch Surg. 1994 Jul;129(7):769-72.
11.
Detwiler SP, Carson JL, Woosley JT, Gambling TM, Briggaman RA. Bubble hair. Case caused by an overheating hair dryer and reproducibility in normal hair with heat.
J Am
Acad Dermatol. 1994 Jan;30(1):54-60.
12.
Domloge-Hultsch N, Anhalt GJ, Gammon WR, Lazarova Z, Briggaman R, Welch M,
Jabs DA, Huff C, Yancey KB. Antiepiligrin cicatricial pemphigoid: a subepithelial bullous disorder. Arch Dermatol. 1994;130:1521-1529.
13.
Chan LS, Fine JD, Briggaman RA, Woodley DT, Hammerberg C, Drugge RJ, Cooper
KD. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease.
J Invest Dermatol. 1993 Sep;101(3):262-7.

14.
Tope WD, Kamino H, Briggaman RA, Rico MJ, Prose NS. Neonatal pemphigus vulgaris in a child born to a woman in remission.
J Am Acad Dermatol. 1993 Sep;29(3):480-5.
15.
Fine JD, Johnson LB, Cronce D, Wright JT, Leigh IM, McCollough M, Briggaman RA.
Intracytoplasmic retention of type VII collagen and dominant dystrophic epidermolysis bullosa: reversal of defect following cessation of or marked improvement in disease activity.
J Invest Dermatol. 1993 Aug;101(2):232-6.
16.
Gammon WR, Briggaman RA. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen.
Dermatol Clin.
1993 Jul;11(3):535-47.
17.
Gammon WR, Murrell DF, Jenison MW, Padilla KM, Prisayanh PS, Jones DA,
Briggaman RA, Hunt SW III. Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain.
J Invest Dermatol. 1993
May;100(5):618-22.
18.
Ceilley E, Watanabe N, Shapiro D, Verrando P, Bauer EA, Burgeson R, Briggaman RA,
Woodley DT. Labeling of fractured human skin with antibodies to BM 600/nicein, epiligrin, kalinin and other matrix components.
J Dermatol Sci. 1993 Apr;5(2):97-103.
19.
Kaiser HW, Ness W, Jungblut I, Briggaman RA, Kreysel HW, O'Keefe EJ. Adherens junctions: demonstration in human epidermis.
J Invest Dermatol. 1993 Feb;100(2):180-5.
20.
Gammon WR, Briggaman RA. Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder.
J Invest Dermatol. 1993
Jan;100(1):28S-34S.
21.
Gammon WR, Abernethy ML, Padilla KM, Prisayanh PS, Cook ME, Wright J,
Briggaman RA, Hunt SW III. Noncollagenous (NC1) domain of collagen VII resembles multidomain adhesion proteins involved in tissue-specific organization of extracellular matrix.
J Invest Dermatol. 1992 Dec;99(6):691-6.
22.
Domloge-Hultsch N, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB.
Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease.
J Clin Invest. 1992
Oct;90(4):1628-33.
23.
Gammon WR, Fine JD, Forbes M, Briggaman RA. Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies.
J Am Acad
Dermatol. 1992 Jul;27(1):79-87.
24.
Woodley DT, Sarret Y, Briggaman RA. Autoimmunity to type VII collagen.
Semin
Dermatol. 1991 Sep;10(3):232-9.
25.
Woodley DT, Yamauchi M, Wynn KC, Mechanic G, Briggaman RA. Collagen telopeptides (cross-linking sites) play a role in collagen gel lattice contraction.
J Invest
Dermatol. 1991 Sep;97(3):580-5.
26.
Stewart MI, Woodley DT, Briggaman RA. Epidermolysis bullosa acquisita and associated symptomatic esophageal webs.
Arch Dermatol. 1991 Mar;127(3):373-7.
27.
Fine JD, Bauer EA, Briggaman RA, Carter DM, Eady RA, Esterly NB, Holbrook KA,
Hurwitz S, Johnson L, Lin A, et al. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on
Diagnosis and Classification of the National Epidermolysis Bullosa Registry.
J Am Acad
Dermatol. 1991 Jan;24(1):119-35.

28.
Woodley DT, Briggaman RA, Gammon WR. Acquired epidermolysis bullosa. A bullous disease associated with autoimmunity to type VII (anchoring fibril) collagen.
Dermatol
Clin. 1990 Oct;8(4):717-26.
29.
Woodley DT, Briggaman RA, Herzog SR, Meyers AA, Peterson HD, O'Keefe EJ.
Characterization of "neo-dermis" formation beneath cultured human epidermal autografts transplanted on muscle fascia.
J Invest Dermatol. 1990 Jul;95(1):20-6.
30.
Woodley DT, Zelickson AS, Briggaman RA, Hamilton TA, Weiss JS, Ellis CN,
Voorhees JJ. Treatment of photoaged skin with topical tretinoin increases epidermaldermal anchoring fibrils. A preliminary report.
JAMA. 1990 Jun 13;263(22):3057-9.
31.
Gammon WR, Kowalewski C, Chorzelski TP, Kumar V, Briggaman RA, Beutner EH.
Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita.
J Am Acad
Dermatol. 1990 Apr;22(4):664-70.
32.
Rusenko KW, Gammon WR, Fine JD, Briggaman RA. The carboxyl-terminal domain of type VII collagen is present at the basement membrane in recessive dystrophic epidermolysis bullosa.
J Invest Dermatol. 1989 Apr;92(4):623-7.
33.
Woodley DT, Briggaman RA. New immunologic techniques for the fine diagnosis of blistering diseases.
Semin Dermatol. 1988 Sep;7(3):178-85.
34.
Gammon WR, Heise ER, Burke WA, Fine JD, Woodley DT, Briggaman RA. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class
II allele associated.
J Invest Dermatol. 1988 Sep;91(3):228-32.
35.
Woodley DT, Briggaman RA, Gammon WT. Review and update of epidermolysis bullosa acquisita.
Semin Dermatol. 1988 Jun;7(2):111-22.
36.
Woodley DT, Peterson HD, Herzog SR, Stricklin GP, Burgeson RE, Briggaman RA,
Cronce DJ, O'Keefe EJ. Burn wounds resurfaced by cultured epidermal autografts show abnormal reconstitution of anchoring fibrils.
JAMA. 1988 May 6;259(17):2566-71.
37.
Gammon WR, Briggaman RA. Absence of specific histologic changes in guinea pig skin treated with bullous pemphigoid antibodies.
J Invest Dermatol. 1988 Apr;90(4):495-500.
38.
Woodley DT, Burgeson RE, Lunstrum G, Bruckner-Tuderman L, Reese MJ, Briggaman
RA. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen.
J Clin Invest. 1988 Mar;81(3):683-7.
39.
Yoshiike T, Woodley DT, Briggaman RA. Epidermolysis bullosa acquisita antigen: relationship between the collagenase-sensitive and -insensitive domains.
J Invest
Dermatol. 1988 Feb;90(2):127-33.
40.
Marks VJ, Briggaman RA. Pyoderma faciale: successful treatment with isotretinoin.
J
Am Acad Dermatol. 1987 Dec;17(6):1062-3.
41.
Gammon WR, Briggaman RA. Functional heterogeneity of immune complexes in epidermolysis bullosa acquisita.
J Invest Dermatol. 1987 Nov;89(5):478-83.
42.
O'Keefe EJ, Briggaman RA, Herman B. Calcium-induced assembly of adherens junctions in keratinocytes.
J Cell Biol. 1987 Aug;105(2):807-17.
43.
Woodley DT, O'Keefe EJ, McDonald JA, Reese MJ, Briggaman RA, Gammon WR.
Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen.
J
Clin Invest. 1987 Jun;79(6):1826-30.
44.
O'Keefe EJ, Woodley DT, Falk RJ, Gammon WR, Briggaman RA. Production of fibronectin by epithelium in a skin equivalent.
J Invest Dermatol. 1987 May;88(5):634-9.

45.
Wernikoff S, Merritt C, Briggaman RA, Woodley DT. Malignant pyoderma or pyoderma gangrenosum of the head and neck?
Arch Dermatol. 1987 Mar;123(3):371-5.
46.
Salomon RJ, Briggaman RA, Wernikoff SY, Kayne AL. Localized bullous pemphigoid.
A mimic of acute contact dermatitis.
Arch Dermatol. 1987 Mar;123(3):389-92.
47.
Woodley DT, Scheidt VJ, Reese MJ, Paller AS, Manning TO, Yoshiike T, Briggaman
RA. Localization of the alpha 3 (V) chain of type V collagen in human skin.
J Invest
Dermatol. 1987 Mar;88(3):246-52.
48.
Woodley DT, Ernst T, Reese MJ, Ogden NM, Gammon WR, Briggaman RA, Falk RJ.
Neonatal foreskin substrate has limitations for the immunofluorescent screening of monoclonal antibodies.
J Invest Dermatol. 1987 Feb;88(2):167-71.
49.
Woodley DT, Briggaman RA, Gammon WR, Falk RJ, Reese MJ, Tomsick RS, O'Keefe
EJ. Epidermolysis bullosa acquisita antigen, a major cutaneous basement membrane component, is synthesized by human dermal fibroblasts and other cutaneous tissues.
J
Invest Dermatol. 1986 Aug;87(2):227-31.
50.
Petersen MJ, Gammon WR, Briggaman RA. A case of linear IgA disease presenting initially with IgG immune deposits.
J Am Acad Dermatol. 1986 Jun;14(6):1014-9.
51.
Woodley DT, O'Keefe EJ, Reese MJ, Mechanic GL, Briggaman RA, Gammon WR.
Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains.
J Invest Dermatol. 1986
Jun;86(6):668-72.
52.
Paller AS, Queen LL, Woodley DT, Lane AT, Gammon WR, Briggaman RA. Organspecific, phylogenetic, and ontogenetic distribution of the epidermolysis bullosa acquisita antigen.
J Invest Dermatol. 1986 Apr;86(4):376-9.
53.
Burke WA, Merritt CC, Briggaman RA. Disseminated extramedullary plasmacytomas.
J
Am Acad Dermatol. 1986 Feb;14(2 Pt 2):335-9.
54.
Burke WA, Briggaman RA, Gammon WR. Epidermolysis bullosa acquisita in a patient with multiple endocrinopathies syndrome.
Arch Dermatol. 1986 Feb;122(2):187-9.
55.
Woodley DT, Briggaman RA, Gammon WR, O'Keefe EJ. Epidermolysis bullosa acquisita antigen is synthesized by human keratinocytes cultured in serum-free medium.
Biochem Biophys Res Commun. 1985 Aug 15;130(3):1267-72.
56.
Briggaman RA, Gammon WR, Woodley DT. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid).
J Invest Dermatol. 1985 Jul;85(1
Suppl):79s-84s.
57.
DeCastro P, Jorizzo JL, Rajaraman S, Solomon AR Jr, Briggaman RA, Raimer SS.
Localized vulvar pemphigoid in a child.
Pediatr Dermatol. 1985 Jul;2(4):302-7.
58.
Gammon WR, Woodley DT, Dole KC, Briggaman RA. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen.
J Invest Dermatol. 1985 Jun;84(6):472-6.
59.
Marks VJ, Briggaman RA, Wheeler CE Jr. Hyperpigmentation in megaloblastic anemia.
J Am Acad Dermatol. 1985 May;12(5 Pt 2):914-7.
60.
Briggaman RA. Is there any specificity to defects of anchoring fibrils in epidermolysis bullosa dystrophica, and what does this mean in terms of pathogenesis?
J Invest
Dermatol. 1985 May;84(5):371-3.
61.
Paller AS, Queen LL, Woodley DT, Gammon WR, O'Keefe EJ, Briggaman RA. A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen.
J Invest Dermatol. 1985 Mar;84(3):215-7.

62.
Gammon WR, Briggaman RA, Woodley DT, Heald PW, Wheeler CE Jr. Epidermolysis bullosa acquisita--a pemphigoid-like disease.
J Am Acad Dermatol. 1984 Nov;11(5 Pt
1):820-32.
63.
Briggaman RA, Schechter NM, Fraki J, Lazarus GS. Degradation of the epidermaldermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes.
J Exp Med. 1984 Oct 1;160(4):1027-42.
64.
Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO, Queen LL, Gammon WR.
Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.
N Engl J Med. 1984 Apr 19;310(16):1007-13.
65.
Gammon WR, Briggaman RA, Inman AO 3rd, Queen LL, Wheeler CE. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.
J Invest Dermatol. 1984
Feb;82(2):139-44.
66.
Goldsmith LA, Briggaman RA. Monoclonal antibodies to anchoring fibrils for the diagnosis of epidermolysis bullosa.
J Invest Dermatol. 1983 Nov;81(5):464-6.
67.
Gammon WR, Briggaman RA, Inman AO 3rd, Merritt CC, Wheeler CE Jr. Evidence supporting a role for immune complex-mediated inflammation in the pathogenesis of bullous lesions of systemic lupus erythematosus.
J Invest Dermatol. 1983 Oct;81(4):320-
5.
68.
Fraki JE, Briggaman RA, Lazarus GS. Transplantation of psoriatic skin onto nude mice.
J
Invest Dermatol. 1983 Jun;80 Suppl:31s-35s.
69.
Briggaman RA. Hereditary epidermolysis bullosa with special emphasis on newly recognized syndromes and complications. Dermatologic Clinics. 1983;1:263-279.
70.
Goldsmith LA, Briggaman RA. Monoclonal antibodies to normal and abnormal epithelial antigens.
Curr Probl Dermatol. 1983;11:3-25.
71.
Gammon WR, Robinson T, Briggaman RA, Wheeler CE Jr. Double immunofluorescence microscopy: a method for localizing immune deposits in skin diseases associated with linear basement membrane zone immunofluorescence.
J Invest Dermatol. 1982
Nov;79(5):312-7.
72.
Olansky AJ, Briggaman RA, Gammon WR, Kelly TF, Sams WM Jr. Bullous systemic lupus erythematosus.
J Am Acad Dermatol. 1982 Oct;7(4):511-20.
73.
Gammon WR, Briggaman RA, Wheeler CE Jr. Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease.
J Am Acad Dermatol. 1982 Sep;7(3):382-
7.
74.
Briggaman RA. Epidermal-dermal interactions in adult skin.
J Invest Dermatol. 1982
Jul;79 Suppl 1:21s-24s.
75.
Fraki JE, Briggaman RA, Lazarus GS. Uninvolved skin from psoriatic patients develops signs of involved psoriatic skin after being grafted onto nude mice.
Science. 1982 Feb
5;215(4533):685-7.
76.
Briggaman RA. Biochemical composition of the epidermal-dermal junction and other basement membrane.
J Invest Dermatol. 1982 Jan;78(1):1-6.
77.
Briggaman RA, Wheeler CE Jr. Immunology of human warts.
J Am Acad Dermatol.
1979 Oct;1(4):297-304.
78.
Jorizzo JL, Gammon WR, Briggaman RA. Cutaneous plasmacytomas. A review and presentation of an unusual case.
J Am Acad Dermatol. 1979 Jul;1(1):59-66.

79.
Long JC, Wheeler CE Jr, Briggaman RA. Varicella-like infection due to herpes simplex.
Arch Dermatol. 1978 Mar;114(3):406-9.
80.
Komorous JM, Wheeler CE, Briggaman RA, Caro I. Intrauterine herpes simplex infections.
Arch Dermatol. 1977 Jul;113(7):918-22.
81.
Briggaman RA. The aromatic diamidines.
Int J Dermatol. 1977 Apr;16(3):155-62.
82.
Wheeler CE Jr, Briggaman RA, Caro I. Shortage of full-time faculty in dermatology.
Arch Dermatol. 1977 Mar;113(3):297-301.
83.
Schupbach CW, Wheeler CE Jr, Briggaman RA, Warner NA, Kanof EP. Cutaneous manifestations of disseminated cryptococcosis.
Arch Dermatol. 1976 Dec;112(12):1734-
40.
84.
Briggaman RA, Wheeler CE Jr. Lamellar ichthyosis: long-term graft studies on congenitally athymic nude mice.
J Invest Dermatol. 1976 Nov;67(5):567-76.
85.
Crawford EG Jr, Burkes EJ Jr, Briggaman RA. Hereditary epidermolysis bullosa: oral manifestations and dental therapy.
Oral Surg Oral Med Oral Pathol. 1976 Oct;42(4):490-
500.
86.
Osteen FB, Wheeler CE Jr, Briggaman RA, Puritz EM. Pemphigus foliaceus. Early clinical appearance as dermatitis herpetiformis with eosinophilic spongiosis.
Arch
Dermatol. 1976 Aug;112(8):1148-52.
87.
Briggaman RA, Wheeler CE Jr. Epidermolysis bullosa dystrophica-recessive: a possible role of anchoring fibrils in the pathogenesis.
J Invest Dermatol. 1975 Aug;65(2):203-11.
88.
Briggaman RA, Wheeler CE Jr. The epidermal-dermal junction.
J Invest Dermatol. 1975
Jul;65(1):71-84.
89.
Stanley RJ, Puritz EM, Briggaman RA, Wheeler CE Jr. Sensory radicular neuropathy.
Arch Dermatol. 1975 Jun;111(6):760-2.
90.
Orlando RC, Bozymski EM, Briggaman RA, Bream CA. Epidermolysis bullosa: gastrointestinal manifestations.
Ann Intern Med. 1974 Aug;81(2):203-6.
91.
Wheeler CE Jr, Briggaman RA, Lynch PJ, Miller LH. Shortage of full-time faculty in dermatology.
Arch Dermatol. 1973 Apr;107(4):529-32.
92.
Wheeler CE Jr, Briggaman RA, Puritz EM. Corticosteroids in the treatment of skin disorders.
Am Fam Physician. 1973 Jan;7(1):130-40.
93.
Wheeler CE Jr, Lynch PJ, Briggaman RA, Miller LH. The influence of NIH training grants in dermatology on the growth and development of American dermatology.
Arch
Dermatol. 1972 May;105(5):676-80.
94.
Briggaman RA, Dalldorf FG, Wheeler CE Jr. Formation and origin of basal lamina and anchoring fibrils in adult human skin.
J Cell Biol. 1971 Nov;51(21):384-95.
95.
Briggaman RA, Wheeler CE Jr. Epidermal-dermal interactions in adult human skin. II.
The nature of the dermal influence.
J Invest Dermatol. 1971 Jan;56(1):18-26.
96.
Cohn BA, Wheeler CE Jr, Briggaman RA. Scleredema adultorum of Buschke and diabetes mellitus.
Arch Dermatol. 1970 Jan;101(1):27-35.
97.
Wheeler CE Jr, Briggaman RA. Growth of herpes simplex virus in adult human skin organ cultures.
Proc Soc Exp Biol Med. 1969 Nov;132(2):405-8.
98.
Wheeler CE Jr, Briggaman RA, Henderson RR. Discrimination between two strains
(types) of Herpes simplex virus by various modifications of the neutralization test.
J
Immunol. 1969 May;102(5):1179-92.
99.
Briggaman RA, Wheeler CE Jr. Epidermal-dermal interactions in adult human skin: role of dermis in epidermal maintenance.
J Invest Dermatol. 1968 Dec;51(6):454-65.

100.
Wheeler CE Jr, Briggaman RA, Henderson RR. Plaque titration of herpes simplex with antibody-free liquid overlay.
Proc Soc Exp Biol Med. 1968 Mar;127(3):814-8.
101.
Wheeler CE Jr, Abele DC, Briggaman RA. Skin manifestations of internal malignancy.
Postgrad Med. 1967 May;41(5):494-500.
102.
Briggaman RA, Abele DC, Harris SR, Wheeler CE Jr. Preparation and characterization of a viable suspension of postembryonic human epidermal cells.
J Invest
Dermatol. 1967 Feb;48(2):159-68.